REVIEW

METABOLIC SYNDROME AND REPRODUCTION: CURRENT PERSPECTIVES IN NIGERIA

Olulope Ajayi , Mabel Charles-Davies

Olulope Ajayi
Edo University Iyamho, Edo State. Email: olufema01@yahoo.co.uk

Mabel Charles-Davies
Department of Chemical Pathology, College of Medicine, University of Ibadan, Nigeria
Online First: January 15, 2019 | Cite this Article
Ajayi, O., Charles-Davies, M. 2019. METABOLIC SYNDROME AND REPRODUCTION: CURRENT PERSPECTIVES IN NIGERIA. Diabesity 5(1). DOI:10.15562/diabesity.2019.57


Metabolic syndrome (MS) is a clustering of cardiovascular disease risk factors. It is a major health challenge globally, with an increased prevalence in the developing world. Studies on its role on reproduction in Nigeria are currently sparse. This article therefore, examines current knowledge on metabolic syndrome and reproduction in Nigerians. Academic databases including PubMed as well as Google search engine were searched between 2012 and 2019 for metabolic syndrome in reproduction in Nigerian males and females. Current observations suggest that metabolic syndrome adversely affects reproduction.

References

Elsamanoudy AZ, Abdalla HA, Hassanien M, Gaballah M. Spertozoal cell death-inducing DNA fragmentation factor-α-like effector A (CIDEA) gene expression and DNA fragmentation in infertile men with metabolic syndrome and normal seminogram. Diabetol Metab Syndr. 2016; 8: 76. doi: 10.1186/s13098-016-0192-y

Bhandari R, Kelley GA, Hartley TA and Rockett IRH. Metabolic Syndrome Is Associated with Increased Breast Cancer Risk: A Systematic Review with Meta-Analysis. Int J Breast Cancer. 2014; 2014: 189384. doi: 10.1155/2014/189384

Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA and Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young Adults: A pooled analysis. Prev Med Rep. 2017; 7: 211-215. doi: 10.1016/j.pmedr.2017.07.004

O’Neill S and O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015; 16(1): 1-12. doi: 10.1111/obr.12229

Kaur J. A comprehensive review of metabolic syndrome. Cardiol. Res. Pract. 2014; 2014: 943162. doi: 10.1155/2014/943162

Fabian UA,Charles-Davies MA, Fasanmade AA, Olaniyi JA, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan O, Ajobo BM, Ebesunun MO, Adigun K, Akinlade KS, Arinola OG and Agbedana EO. Sex hormones and their relationship with leptin and cardiovascularrisk factors in pre and postmenopausal Nigerian women with metabolic syndrome. Cardiology and Angiology: An international Journal. 2015; 3: 149-156. doi : 10.9734/CA/2015/15236

Vorster HH. The emergence of cardiovascular disease during urbanization of Africans. Public Health Nutr. 2002; 5: 239–243

Charles-Davies MA, Fasanmade AA, Olaniyi JA, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan O, Ajobo MT, Ebesunun MO, Adigun K, Akinlade KS, Fabian UA, Popoola OO, Rahamon SK, Okunbolade W, Ogunlakin MA, Arinola OG, Agbedana EO. Prevalent Components of Metabolic Syndrome and Their Correlates in Apparently Healthy Individuals in Sub-saharan Africa. International Journal of Tropical Disease & Health. 2014; 4: 740-752. doi: 10.9734/IJTDH/2014/5864

Osuji CU, Nzerem BA, Dioka CE, Onwubuya EI. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi Experience. Nig. J. Clinic. Prac. 2012; 15: 475-480.doi: 10.4103/1119-3077.104530

Akbar DH. Metabolic syndrome is common in Saudi types 2 diabetic patients. Diabetes Int. 2002; 12: 47-49

Kumar S, Agrawal D, Sharma K, Swain TR. Association of male infertility to metabolic syndrome and other related disorders. J. Integr. Nephr. Androl. 2015, 2, 107-116

Uadia PO and Emokpae AM. Male infertility in Nigeria: a neglected reproductive health issue requiring attention. Journal of Basic and Clinical Reproductive Sciences 2015; 4: 45-53.

Reilly CM, Zamorano P, Stopper VS, Mills TM. Androgenic regulation of NO availability in rat penile erection. J. Androl. 1997; 18: 110-115.

Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J. Androl. 2009; 30: 23-32. doi: 10.2164/jandrol.108.005751

Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 1997; 337: 91-95.doi:10.1056/NEJM199707103370204

Fabian UA, Charles-Davies MA, Fasamade AA, Olaniyi JA, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan OO, Ajobo BM, Ebesunun MO, Adigun K, Akinlade KS, Arinola OG, Agbedana EO. Male Sexual Dysfunction, Leptin, Pituitary and Gonadal Hormones in Nigerian Males with Metabolic Syndrome and Type 2 Diabetes Mellitus. J Reprod. Infertil. 2016; 17: 17-25.

Akinloye O, Popoola BB, Ajadi MB, Uchechukwu JG and Oparinde DP. Hypogonadism and Metabolic Syndrome in Nigerian Male Patients With Both Type 2 Diabetes and Hypertension. Int’l. J. Endocrinol. Metab. 2013; 12: e10749. doi: 10.5812/ijem.10749

Suleiman JB, Abu Bakar AB, Mohamed M. Review on effects of obesity on male reproductive system and the role of natural products. J App Pharm Sci. 2019; 9(01): 131-141

Ajayi AB, Afolabi BM, Ajayi VD, Oyetunji IO, Atiba A, Saanu S, Adeoye AT, Adeshida TE, Ehichioya J, Ayelehin II. Evaluation of Sperm DNA Fragmentation amongst Infertile Black Africans. A Nigerian Study. Open J Urol. 2018; 8: 297-316

O’Flynn N. Assessment and treatment for people with fertility problems: NICE guideline. Br. J. Gen. Prac. 2014; 64: 50-5.1 doi: 10.3399/bjgp14X676609

Noreh LJ, Tucs O, Sekadde-Kigondu CB, Noreh JA. Outcomes of assisted reproductive technologies at the Nairobi In Vitro Fertilisation Centre. East Afr. Med. J. 2009, 86, 156-161

Sharma S, Mittal S and Aggarwal P. Management of infertility in low resource countries. BJOG. 2009; 77-83.doi:10.1111/j.1471-0528.2009.02311.x

Haws RA, Mashasi I, Mrisho M, Schellenberg JA, Darmstadt GL, Winch PJ. These are not good things for other people to know": how rural Tanzanian women's experiences of pregnancy loss and early neonatal death may impact survey data quality. Soc. Sci. Med. 2010; 71: 1764-1772. doi: 10.1016/j.socscimed.2010.03.051

Nasreddine L, Naja F, Tabet M, Habbal MZ, El-Aily A, Haikal C, Sidani S, Adra N, Hwalla N. Obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents. Ann. Hum. Biol. 2012; 39: 122-128. doi: 10.3109/03014460.2012.655776

Aliyu Y, Adesiyun AG, Avidime S, Randawa AJ. Prevalence of obesity and outcome of weight loss on reproduction: A study among women attending infertility clinic in Zaria, Northern Nigeria. Arch Med Surg. 2017; 2(1): 3-6

De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgini R. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin b levels in fertile women. Obesity. 2006; 14: 1954-1960.doi:10.1038/oby.2006.228

Agbaje IM, Rogers DA, McVicar, CM, McClure N, Atkinson AB, Mallidis C, Levis SEM. Insulin Dependent Diabetes Mellitus: Implication for Male Reproductive function. Hum. Reprod. 2007; 22: 1871-1877. doi:10.1093/humrep/dem077

Digban KA, Adu ME, Jemikalajah JD, Adama S. Hormonal profile of some infertile women in Bida Nigeria. Libyan J Med Sci. 2018; 2(1): 26-28

ACOG Committee on Practice Bulletins – Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 2002; 99: 159-167.

Udenze IC. Association of pre- eclampsia with metabolic syndrome and increased risk of cardiovascular disease in women: A systemic review. Niger. J. Clin. Prac. 2016; 19: 431-435. doi: 10.4103/1119-3077.180055

Reslan OM and Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovas. Hematol. Agents Med Chem. 2010; 8: 204-26

Okoye H, Chinawa J, Aniwada EC, Eweputanna L, Nwagha U. Thrombogenic indices in an evaluation of pregnant Nigerian women with pregnancy loss. Trop J Obstet Gynaecol. 2019; 36: 122-125

Romuald R, Ratsiatosika TA, Martial RA, Lantonirina RA, Ando-Miora R, Rakotovao AH. The women knowledge, attitude and perceptions of pre-eclampsia and eclampsia in Madagascar. Int J Reprod Contracept Obstet Gynecol. 2019; 8(4):1233-1239

Osungbade KO and Ige OK. Public health perspectives of preeclampsia in developing countries: Implication for health system strengthening. J. Preg. 2011: 2011; 481095. doi: 10.1155/2011/481095

Oladapo O, Adetoro O, Ekele B, Charma C, Etuk S, Aboyeji A et al. When getting there is not enough: a nationwide cross sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country. BJOG An Int J Obstet Gynaecol. 2015. Doi: 10.11

Musa J, Mohammed C, Ocheke A, Kahansim M, Pam V, Daru P. Incidence and risk factors for preeclampsia in Jos, Nigeria. Afr Health Sci. 2018; 18(3): 584-595

Babah OA, Oluwole AA, Ayanbode OS, Ohazurike EO. Obesity and preeclampsia: role of fibrinogen and C-reative protein. Trop J Obstet Gynaecol. 2017; 34(1): 45-48. Doi: 10.4103/TJOG.TJOG_15_17

Bastard JP, Maachi M, Lagamu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12

Onuegbu AJ, Olisekodiaka JM, Udo JU, Umeononihu O, Amah UK, Okwara JE, Atuegbu C. Evaluation of High-Sensitivity C-Reactive Protein and Serum Lipid Profile in Southeastern Nigerian Women with Pre-Eclampsia. Med Princ Pract 2015;24:276-279. https://doi.org/10.1159/000381778

Akinlade KS, Adediji IO, Rahamon SK, Fawole AO, Tongo OO. Serum copeptin and pregnancy outcome in preeclampsia. Niger Med J. 2015; 56: 362-368

Eltabakh SMM, Zeidan M, Maged H, Zikry M and Khedr M. Copeptin as a Novel Biomarker of Obesity-Induced Insulin Resistance and Metabolic Syndrome. Diabetes 2018; 67(Supplement 1) https://doi.org/10.2337/db18-1514-P

von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Front Biosci. 2007; 12: 2457-2470

Teede H, Deeks A, Moran L. polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine. 2010; 8: 41. doi: 10.1186/1741-7015-8-41

Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, and Hudita D. The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms. J Med. Life. 2015; 8: 142–145

Ugwu GO, Iyoke CA, Onah HE, Mba SG. Prevalence, presentation and management of polycystic ovary Syndrome in Enugu, south east Nigeria. Niger. J. Med. 2013; 22: 313-316

Omokanye LO, Ibiwoye-Jaiyeola OA, Olatinwo A, Abdul IF, Durowade KA, Biliaminu SA. Polycystic ovarian syndrome: Analysis of management outcomes among infertile women at a public health institution in Nigeria. Niger. J. Gen. Pract. 2015; 13: 44-48 doi: 10.4103/1118-4647.170152

Akpata CB, Uadia PO, Okonofua FE . Prevalence of Polycystic Ovary Syndrome in Nigerian Women with Infertility: A Prospective Study of the Three Assessment Criteria. Open J Obstet Gynecol. 2018; 8: 1109-1120. doi: 10.4236/ojog.2018.812112

Scarpitta AM and Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol. 2000; 14: 392-395

Bello FA and Odeku AO. Polycystic Ovaries: A common feature in transvaginal scans of gynaecological patients. Ann. Ib. Postgrad. Med. 2015; 13: 108-109

Tabrizi FPF, Alipoor B, Sadaghiani MM, Ostadrahimi A, Mahdvahi AM. Metabolic syndrome and its characteristics among reproductive-aged women with polycystic ovary syndrome: A cross-sectional study in Northwest Iran. Int J Fertil Steril. 2013; 6: 244-249

Spinedi E and Cardinali DP. The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy. Int J Endocrinol. 2018, Article ID 1349868, 12 pages https://doi.org/10.1155/2018/1349868

Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS and Ghazzi MN; PCOS/Troglitazone Study Group, : Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 91:48–53. 2006.

Oriji VK and Nyengidiki K. Ovulation Induction in Women with Polycystic Ovary Syndrome: What is the Optimal Option? Intech open science, open mind. 2017; 79-88. http://dx.doi.org/10.5772/intechopen.70812

Amadi C and Green KI. Relationship between glucose homeostatic disorders and testosterone in adult Nigerian women with polycystic ovary syndrome. Int J Reprod, Contracept Obstet Gynecol. 2018; 7(11). Doi:http://dx.doi.org/10.18203/2320-1770.ijrcog20184474

Green KI and Amadi C. The impact of BMI and plasma glucose and lipid status of women with polycystic ovary syndrome. Int J Res Med Sci. 2018; 6(12): 3832-3837. Doi: http://dx.doi.org/10.18203/2320-6012.ijrms20184878

Deshmukh S. Polycystic ovarian syndrome. In: Allahbadia GN. Infertility management made easy.Tunbridge Wells: Anshan Ltd; 2007. pp. 172–197.

Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod. 2009; 24: 1548–1555. doi: 10.1093/humrep/dep049

Yao K, Bian C and Zhao X. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy (Review). Exp Ther Med. 2017; 14(2): 1271-1276. https://doi.org/10.3892/etm.2017.4642

He Y, Yao Lu, Zhu Q, Wang Y, Lindheim SR, Qi J, Li X, Ding Y, Shi Y, Wei D, Chen ZJ, Sun Y. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol. 2019; pii: S0002-9378(19)30489-2. doi: 10.1016/j.ajog.2019.03.011.


Article Views      : 0
PDF Downloads : 0